Very early researchUnknownNCT05566600
What this trial is testing
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
Who this might be right for
Ischemic Heart FailureChronic Heart Failure
HELP Therapeutics Co., Ltd. 32